ARCUS BIOSCIENCES INC (RCUS)
NYSE • Healthcare
Last close at July 2, 2026 at 20:00 UTC
Fundamentals Charts
About ARCUS BIOSCIENCES INC
Arcus Biosciences, Inc. (NYSE: RCUS) is a clinical-stage biopharmaceutical company in biotechnology that discovers and aims to commercialize cancer therapies. In FY2025, the company recorded $247.0 million in revenue. Its drug portfolio centers on immuno-oncology and targeted treatment candidates for solid tumors and genetically defined disease.
Analyst Ratings
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings Calendar
Technical Indicators
ARCUS BIOSCIENCES INC's Technical Indicators Summary
RCUS trades around $30.33 and is above its short-, medium- and long-term moving averages, with the 200-day well below current price, and ADX indicates a strengthening trend. Momentum and MACD read positively and RSI is supportive, while OBV confirms buying interest. ATR shows elevated percentage volatility, suggesting price moves are relatively volatile, and the pivot sits just under the market, offering near-term support. The technical evidence favors continued accumulation. Technical takeaway: Strong Buy.
| Indicator | Value |
|---|---|
RSI (14) | 65.68 |
Stochastic %K (14, 3, 3) | 81.76 |
CCI (20) | 88.06 |
WPR (14) | -16.65 |
Momentum (10) | 6.21 |
MFI | 91.20 |
MACD Level (12, 26) | 1.70 |
Bollinger Bands | $19.91 - $32.77 |
ATR (14) | $1.65 (5.44%) |
ADX (14) | 26.83 |
OBV | 48,169,112 |
Classic Pivot Point | $29.67 |
Fibonacci Pivot Point | $29.67 |
Simple Moving Averages | $21.76 - $29.09(5 indicators) |
Exponential Moving Averages | $20.89 - $28.95(5 indicators) |
Get premium market insights delivered directly to your inbox.
Today's Snapshot
The session wrapped with RCUS still elevated after a strong 5.05% gap versus yesterday. Into the close, RCUS still showed subdued interest, with volume at 0.47× its norm. End-of-day, the peer group was firmly higher (2.65%), reinforcing a risk-on tone.
Trading Volume
0
vs S&P 500 Today
Outperforming Market
+1.79%
52-Week Position
Near highs
94.3%
Updated: July 2, 2026 at 20:05 UTC